Țară: Canada
Limbă: engleză
Sursă: Health Canada
DEXAMETHASONE
PHARMASCIENCE INC
H02AB02
DEXAMETHASONE
0.5MG
ELIXIR
DEXAMETHASONE 0.5MG
ORAL
100ML
Prescription
ADRENALS
Active ingredient group (AIG) number: 0106303010; AHFS:
MARKETED
1992-12-31
_ _ _pms-DEXAMETHASONE ELIXIR _ _Page 1 of 31_ PRESCRIBING INFORMATION PR PMS-DEXAMETHASONE ELIXIR Dexamethasone Elixir, USP 0.5 mg / 5 mL Corticosteroid Pharmascience Inc. 6111 Royalmount Avenue, Suite 100 Montréal, QC, Canada H4P 2T4 Date of Revision: June 06, 2022 Submission Control Number: 259974 _ _ _ _ _pms-DEXAMETHASONE ELIXIR _ _Page 2 of 31_ TABLE OF CONTENTS 1 INDICATIONS .............................................................................................................. 3 2 CONTRAINDICATIONS ................................................................................................. 4 3 DOSAGE AND ADMINISTRATION................................................................................. 5 4 OVERDOSAGE ............................................................................................................. 7 5 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING ................................. 7 6 WARNINGS AND PRECAUTIONS .................................................................................. 8 6.1 Special Populations .......................................................................................... 14 6.1.1 Pregnant Women ....................................................................................... 14 6.1.2 Breast-feeding............................................................................................ 15 6.1.3 Pediatrics ................................................................................................... 15 6.1.4 Geriatrics ................................................................................................... 15 7 ADVERSE REACTIONS ................................................................................................ 16 8 DRUG INTERACTIONS................................................................................................ 18 9 CLINICAL PHARMACOLOGY ....................................................................................... 20 10 STORAGE, STABILITY AND DISPOSAL ................. Citiți documentul complet